Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
about
Gene therapy in Parkinson's disease: rationale and current statusAllopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's diseaseExcess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests.UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.Ubiquitin C-terminal hydrolase l1 is expressed in mouse pituitary gonadotropes in vivo and gonadotrope cell lines in vitro.Proteomic profiling of the epileptic dentate gyrus.rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.Transgenic animal models of neurodegeneration based on human genetic studies.AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.Parkinson's disease mouse models in translational research.α-Synuclein and neuronal cell death.Parkinson's disease: from genetics to treatments.Therapeutic strategies in Parkinson's disease: what we have learned from animal models.Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury.Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons.NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease.Toxin-induced and genetic animal models of Parkinson's diseasePilot study: molecular risk factors for diagnosing sporadic Parkinson's disease based on gene expression in blood in MPTP-induced rhesus monkeys.Parkinson's disease: experimental models and reality.Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.Novel UCHL1 mutations reveal new insights into ubiquitin processing.
P2860
Q22241423-C2CD563B-D69E-43B7-8D58-07DECA5DA162Q27334826-6F9DF0B6-4E1F-4DD2-9525-0EFF4953AFD6Q28732131-A2009DE3-4CB8-4651-AAA1-C2CA71F6021CQ29248402-7466AD56-1AC5-42A4-8B67-604C132345DFQ31077544-14BF41B2-4127-4384-B5C6-AFAC5C858445Q33906476-864A5DBD-688E-444B-B235-BA1511D037CDQ34163790-736D6CE3-E091-4CBD-A3B2-DFCEA749B8A4Q34183008-D765A09D-E15A-4DE5-AE29-C388AF848717Q34465572-80A4DBDC-055D-4B56-AE40-48EF3A46064DQ34890228-76A51AC3-599B-4106-A201-D7536E0D26D5Q37618665-4213C4CC-95CA-4563-9285-D7B5C6751CE9Q37874160-BCCB692F-EDE9-454D-84FD-71C65509414CQ38039369-7F151A76-DEB0-4203-842E-BF18A074BC48Q38057859-1F92B2C7-D052-476D-A05D-87FB6223F60EQ38290759-9A1747D2-25BC-4BC2-8484-EAF526BB6302Q38843289-E052729B-9772-49C2-BA29-96EF91F9D09FQ38872092-3BBC03BE-9477-4B5B-8B01-4910C9388B68Q38993636-60E89501-AF2A-4DA4-A5B2-69F848693617Q41427586-74B4AADA-F5F2-4897-9978-31112B904322Q41605202-6308395F-2815-4046-AF51-6C4F08DBE9F8Q47124757-FC559CF8-C536-4BCE-9F9C-11C675CC2B96Q47389506-3E56F18E-C207-493B-AD8C-58326E716157Q48514121-C41EF351-791C-4F6E-887F-96DE5744F1D4Q51241428-B9B74FA2-784C-43C1-9C52-6C421DAFFA5C
P2860
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
@en
type
label
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
@en
altLabel
Effects of UCH-L1 on α-synuclein over-expression mouse model of Parkinson’s disease
@en
prefLabel
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
@en
P2093
P1476
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
@en
P2093
Hideki Mochizuki
Keiichiro Wada
Keiji Wada
Rieko Setsuie
Tomohiro Kabuta
Tomoko Nihira
Toru Yasuda
Xu-Qing Cao
Yong-Ri Ren
P304
P356
10.1111/J.1471-4159.2008.05827.X
P407
P577
2009-01-07T00:00:00Z